Annual Dutch Diabetes Research Meeting 2011 Bohn Stafleu van Loghum Report 17 March 2015 Pages: 83 - 90
PS1 - 1. Insulin detemir increases cerebral glucose metabolism compared to NPH insulin in human type 1 diabetes: possible explanation for differences in weight gain? Larissa W. van GolenMarc C. HuismanMichaela Diamant Report 17 March 2015 Pages: 91 - 91
PS1 - 2. Involvement of the hypothalamic Orexin system in Olanzapine induced metabolic side-effects E.M. GiraultE. FoppenA. Kalsbeek Report 17 March 2015 Pages: 91 - 92
PS1 - 3. The relationship between plasma and brain glucose levels under hypoglycemic conditions in humans Kim C.C. van de VenMarinette van der GraafBastiaan E. de Galan Report 17 March 2015 Pages: 92 - 92
PS1 - 4. Widespread decreased white matter tract integrity in T1DM patients with microangiopathy and its relation to cognitive functions Eelco van DuinkerkenPetra J.W. PouwelsMichaela Diamant Report 17 March 2015 Pages: 93 - 93
PS1 - 5. Deep brain stimulation in the nucleus accumbens alters glucose metabolism in rats Charlene DiepenbroekGeoffrey van der PlasseSusanne E. la Fleur Report 17 March 2015 Pages: 93 - 94
PS1 - 6. Cerebral resting-state network changes in patients with type 1 diabetes with and without microangiopathy relate to cognitive functions Jennifer S. ten KulveEelco van DuinkerkenMichaela Diamant Report 17 March 2015 Pages: 94 - 94
PS2 - 7. A 5-day high fat high calorie diet impairs insulin sensitivity in healthy, young, lean male Hindostani but not in Caucasians Leontine E.H. BakkerHanno PijlIngrid M. Jazet Report 17 March 2015 Pages: 95 - 95
PS2 - 8. MIDD or MELAS: that’s not the question. a severe clinical phenotype of the m.3243A>G mutation Heleen de WitHenk-Jan WestenengAart Mudde Report 17 March 2015 Pages: 95 - 96
PS2 - 9. Effect of B- and T-cell deficiency on obesity-induced inflammation and insulin resistance Dov B. BallakRinke StienstraC.J. Tack Report 17 March 2015 Pages: 96 - 96
PS2 - 10. Constant light exposure disturbs circadian rhythm in energy metabolism and insulin sensitivity Claudia P. CoomansSjoerd A. A. van den BergJohanna H. Meijer Report 17 March 2015 Pages: 96 - 97
PS2 - 11. The hypothalamic suprachiasmatic nucleus controls circadian energy metabolism and insulin sensitivity Sjoerd A. A. van den BergClaudia P. CoomansJohanna H. Meijer Report 17 March 2015 Pages: 97 - 98
PS2 - 12. Cholesterol induced inflammation does not exacerbate insulin resistance in lean Ldlr -/- mice Nanda GrubenAnouk FunkeDebby P.Y. Koonen Report 17 March 2015 Pages: 98 - 98
PS3 - 13. Postprandial microvascular function is impaired in men with type 2 diabetes mellitus and those with the metabolic syndrome Renate E. van GenugtenDaniël H. van RaalteMichaela Diamant Report 17 March 2015 Pages: 99 - 99
PS3 - 14. Glyoxalase-I overexpression partially prevents diabetes-induced impaired arteriogenesis in a rat hind limb ischemia model Liang YuOlaf BrouwersCasper Schalkwijk Report 17 March 2015 Pages: 99 - 100
PS3 - 15. Microvascular Dysfunction Increases the Risk of Type 2 Diabetes Mellitus. A meta-analysis Dennis M.J. MurisAlfons J.H.M. HoubenCoen D. A. Stehouwer Report 17 March 2015 Pages: 100 - 100
PS3 - 16. Insulin induced vasoreactivity is dependent on perivascular adipose tissue as well as resistance artery properties after a two-week high fat diet in mice Rick I. MeijerErik H. SernéEtto C. Eringa Report 17 March 2015 Pages: 101 - 101
PS3 - 17. The methylglyoxal-derived AGE tetrahydropyrimidine is increased in plasma of type 1 diabetes mellitus and in atherosclerotic lesions and is associated with sVCAM-1 Marcelle G.A. van EupenMiranda T. SchramCasper G. Schalkwijk Report 17 March 2015 Pages: 101 - 102
PS3 - 18. Advanced glycation endproducts in atherosclerotic plaques: no further increase in patients with diabetes N.M.J. HanssenC.D.A. StehouwerC.G. Schalkwijk Report 17 March 2015 Pages: 102 - 102
PS4 - 19. Expression of lipid genes, but not adipokine genes, in visceral adipose tissue is related to liver damage in obese individuals Marcel WolfsLude FrankeMarten Hofker Report 17 March 2015 Pages: 103 - 103
PS4 - 20. Alterations in the M-CSF gene result in hepatic lipid accumulation in spite of reduced hepatic inflammation Anouk FunkePascal P.H. HommelbergDebby P.Y. Koonen Report 17 March 2015 Pages: 103 - 104
PS4 - 21. IP/OP MR Imaging as an alternative for 1H-MRS to measure Intrahepatic lipid Bram M.W. BrouwersVera B. Schrauwen-HinderlingPatrick Schrauwen Report 17 March 2015 Pages: 104 - 104
PS4 - 22. Endogenous formation of Nε-(Carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis Katrien H.J. GaensPetra M.G. NiessenCasper G. Schalkwijk Report 17 March 2015 Pages: 105 - 105
PS4 - 23. Increased TNF receptor signaling induces non-alcoholic steatohepatitis in mice Marcela Aparicio-VergaraPascal H. HommelbergDebby P.Y. Koonen Report 17 March 2015 Pages: 105 - 106
PS5 - 24. Add-on treatment of GLP-1 agonists in type 2 diabetics treated with insulin: an observational study Wouter T. ZandeeMaria A. SledderingAart H. Bootsma Report 17 March 2015 Pages: 107 - 107
PS5 - 25. Pharmacogenetics in type 2 diabetes: Genetic variation influences metformin treatment response Nienke van LeeuwenJacqueline M. DekkerLeen M. ‘t Hart Report 17 March 2015 Pages: 107 - 108
PS5 - 26. Modulation of GLP-1 secreting L-cells derived from intestinal stem cells Natalia PetersenLéon van GurpEelco de Koning Report 17 March 2015 Pages: 108 - 108
PS5 - 27. Relation of plasma omentin levels to cardiac function in patients with type 2 diabetes and healthy controls: effects of pioglitazone versus metformin Weena J.Y. ChenSabrina GreulichMichaela Diamant Report 17 March 2015 Pages: 109 - 109
PS5 - 28. Pioglitazone treatment improves muscle oxidative capacity and lowers muscle lipid content in diabetic rats Bart WesselsJolita CiapaiteJeanine Prompers Report 17 March 2015 Pages: 109 - 110
PS6 - 29. Predictors of cardiometabolic control up-to-target in screen-detected type 2 diabetes patients. The ADDITION-Netherlands study Jacqueline BerendsKees J. GorterGuy E.H.M. Rutten Report 17 March 2015 Pages: 111 - 111
PS6 - 30. Fasting and postprandial GLP-1 and GIP in relation to alanine aminotransterase and lipid metabolism in the general population M. AlssemaJ.M RijkelijkhuizenJ.M. Dekker Report 17 March 2015 Pages: 111 - 112
PS6 - 31. Plasma levels of Nε-(carboxymethyl)lysine are lower in impaired glucose metabolism and type 2 diabetes, and this is partly explained by central obesity: The Hoorn and CODAM studies Lian EngelenIsabel FerreiraCasper G. Schalkwijk Report 17 March 2015 Pages: 112 - 112
PS6 - 32. The association between physical activity and cardiovascular disease and all-cause mortality in patients with type 1 diabetes mellitus; The EURODIAB Prospective Complications Study Sabita S. Soedamah-MuthuSusanne M.A.J. TielemansEmmanuel Stamatakis Report 17 March 2015 Pages: 113 - 113
PS6 - 33. Development of cardiovascular risk factors in people with central obesity after three years Corine den EngelsenKees J. GorterGuy E. Rutten Report 17 March 2015 Pages: 113 - 114
PS6 - 34. Microvascular function and Body Mass Index development over time, the Amsterdam Growth and Health Longitudinal Study Nienke J. WijnstokTrynke HoekstraJos WR Twisk Report 17 March 2015 Pages: 114 - 114
PS6 - 35. The association between health status and comorbidity in rather wellcontrolled type 2 diabetes patients in primary care Paulien R. WermelingKees J. GorterGuy E.H.M. Rutten Report 17 March 2015 Pages: 115 - 115
PS7 - 36. Prevention of Metabolic Syndrome in IGT subjects in a lifestyle intervention: results from the SLIM study Annemieke Th. den BoerIngrid J.T. HerraetsEllen E. Blaak Report 17 March 2015 Pages: 116 - 116
PS7 - 37. Effects of acute exercise on hepatic lipid content L. BiletB.M.W. BrouwersP. Schrauwen Report 17 March 2015 Pages: 116 - 117
PS7 - 38. Effects of acute endurance exercise on gene expression in skeletal muscle Milène CatoireMarco MensinkSander Kersten Report 17 March 2015 Pages: 117 - 117
PS7 - 39. Insulin-treated patients with type 2 diabetes mellitus display reduced physical activity compared to healthy controls, which is not explained by differences in sleep characteristics Henry JansenGerald VervoortCees Tack Report 17 March 2015 Pages: 118 - 118
PS7 - 40. High IMCL turnover may explain the athlete’s paradox Lauren M. SparksRuth C.R. MeexPatrick Schrauwen Report 17 March 2015 Pages: 118 - 119
PS7 - 41. Exercise therapy in type 2 diabetes: Is daily exercise required to optimize glycemic control? Jan-Willem van DijkKyra TummersLuc J.C. van Loon Report 17 March 2015 Pages: 119 - 119
PS8 - 42. Basal endogenous glucose production and insulin levels are reduced 2 weeks after bariatric surgery with no effect on hepatic and peripheral insulin sensitivity Barbara A. de WeijerEdo AartsMireille J. Serlie Report 17 March 2015 Pages: 120 - 120
PS8 - 43. Short-term Topiramate treatment in obese insulin resistant women does not improve insulin secretion and sensitivity Maria A. SledderingMarieke SnelIngrid M. Jazet Report 17 March 2015 Pages: 120 - 121
PS8 - 44. FcR-γ-chain-/- mice are protected against diet-induced obesity and diet-induced insulin resistance Irene O.C.M. VroegrijkVanessa van HarmelenKo Willems van Dijk Report 17 March 2015 Pages: 121 - 121
PS8 - 45. Insulin resistance in 4-5 year old children with overweight and obesity Eva C. OngeringGianni BoccaPieter J.J. Sauer Report 17 March 2015 Pages: 122 - 122
PS8 - 46. The metabolic effects of Olanzapine and Topiramate in rats and humans Simon EversGertjan van DijkAnton Scheurink Report 17 March 2015 Pages: 122 - 123
PS8 - 47. Treatment with sulodexide, an endothelial glycocalyx-mimetic, improves glucose tolerance in high-fat diet-fed mice Bart J.M. EskensHans VinkJurgen W.G.E. Van Teeffelen Report 17 March 2015 Pages: 123 - 123
PS9 - 48. External validation of the KORA S4/F4 prediction models for the risk of developing type 2 diabetes in older adults: the PREVEND Study Ali AbbasiEva CorpeleijnStephan J.L. Bakker Report 17 March 2015 Pages: 124 - 124
